1.Relationship between Cerebral Arteriovenous Oxygen Difference and Development of Delayed Cerebral Infarction in Patients with Severe Head Injury.
Seung Hwan YOUN ; Joon CHO ; Chang Taek MOON ; Sang Keun CHANG ; Hyung Chun PARK ; Hyeon Seon PARK ; Eun Young KIM
Journal of Korean Neurosurgical Society 2000;29(4):536-542
No abstract available.
Cerebral Infarction*
;
Craniocerebral Trauma*
;
Head*
;
Humans
;
Oxygen*
2.Simultaneous Occurrence of Bilateral Legg-Calve-Perthes Disease in Identical Twins.
Sung Man ROWE ; Taek Rim YOON ; Sung Taek JUNG ; Jong Keun SEON ; Chang Ich HUR
The Journal of the Korean Orthopaedic Association 2004;39(5):553-556
This report describes simultaneous bilateral Legg-Calve-Perthes disease (LCPD) development in four-year-old identical male twins. Moreover, the twins showed head involvement patterns with mirror symmetry. We included a review of the literature on this rare condition and discussed the genetic risks associated with LCPD.
Head
;
Humans
;
Legg-Calve-Perthes Disease*
;
Male
;
Twins, Monozygotic*
3.Clear cell sarcoma of the kidney: a case report.
Joong Seok SEO ; Yong Wook PARK ; Kye Yong SONG ; Seon Taek CHANG
Journal of Korean Medical Science 1989;4(3):149-153
Clear cell sarcoma of the kidney (CCSK) is a highly malignant childhood tumor, distinguished from classic Wilms' tumor by its propensity to metastasize to the skeletal system. Authors described a case of CCSK from a 3-year-old boy in the right kidney, showing various histologic features, such as classic, epithelioid, trabecular, neurilemmoma-like, cystic and entrapped collecting tubular pattern. Ultrastructurally epithelial differentiation was absent. Immunohistochemically, none of the intrinsic tumor cells showed positive staining with the antibodies against the keratin, S-100 protein, carcinoembryonic antigen, vimentin, desmin and myoglobin, suggesting primitive mesenchymal cell in origin.
Child, Preschool
;
Humans
;
Immunohistochemistry
;
Kidney Neoplasms/metabolism/*pathology
;
Male
;
Neoplasm Metastasis
;
Sarcoma/metabolism/*pathology
4.Antitumor activity of adriamycin and the analogue, THP-adriamycin and epirubicin, against human tumor cell lines.
Weon Seon HONG ; Chang Min KIM ; Myung Shick LEE ; Yoon Koo KANG ; Choon Taek LEE ; You Cheoul KIM ; Jhin Oh LEE ; Tae Woong KANG
Journal of the Korean Cancer Association 1991;23(2):259-265
No abstract available.
Cell Line, Tumor*
;
Doxorubicin*
;
Epirubicin*
;
Humans*
5.Loss of the retinoblastoma gene in non-small cell lung cancer.
Choon Taek LEE ; Chang Min KIM ; Jae Ill ZO ; Young Mag SHIM ; Weon Seon HONG ; Jhin Oh LEE ; Tae Woong KANG
Tuberculosis and Respiratory Diseases 1993;40(2):98-103
No abstract available.
Carcinoma, Non-Small-Cell Lung*
;
Genes, Retinoblastoma*
;
Retinoblastoma*
6.Anesthetic Management of Difficult Tracheotomy with Fiberoptic Bronchoscope: A case report.
Chul Ho CHANG ; Dong Woo HAN ; Yong Beom KIM ; Seon Hee CHO ; Yong Taek NAM
Korean Journal of Anesthesiology 2006;50(3):319-321
The purpose of tracheotomy is to obtain secure airway for difficult airway management and long-term lung ventilation. Tracheotomy is an invasive procedure with the possibility of severe complications, but it is the last choice for difficult airway management. To perform tracheotomy is difficult in patients with anatomically distorted trachea, screened trachea by mass, fibrosis or adhesion and obesity. We report the experience of successful tracheotomy in the patient of severely distorted airway due to previous surgeries with the aid of the light illumination of fiberoptic bronchoscope.
Airway Management
;
Bronchoscopes*
;
Fibrosis
;
Humans
;
Lighting
;
Lung
;
Obesity
;
Trachea
;
Tracheotomy*
;
Ventilation
7.Retinopathy of Prematurity and Perinatal Risk Factors.
Mi Jeong HWANG ; Chang Yee CHO ; Young Youn CHOI ; Yang Rae MA ; Seon Taek LIM ; Yeoung Geol PARK
Journal of the Korean Society of Neonatology 1999;6(1):106-115
PURPOSE: The incidence of retinopathy of prematurity(ROP) which is one of the most common cause of childhood blindness has not decreased despite the restricted use of oxygen. There may be other factors responsible for ROP which could not be explained solely by improved survival of very low birth weight infants. We tried to clarify perinatal risk factors that are nrelated to the occurrence of ROP. METHODS: We enrolled 239 infants with gestational ages less than 33 wks or with birth weight less than 1,800 gm who had received ophthalrnologic examination between Jan. 1995 and Dec. 1997. The patients were categorized into two groups,' "No ROP" group as control(n=185) and ROP group as study population(n=54), and we compared the perinatal risk factors between the two. RESULTS: 54(22.6%) out of 239 infants were diagnosed as having ROP. The annual incidence of ROP decreased but the incidence of treated ROP increased. The incidence of ROP decreased with longer gestation and higher birth weight. Mean gestational age was 30.3 weeks in the study group vs 31.0 weeks in the control group, and mean birth weight was 1,390 gm and 1,586 gm, respectively. Significant factors contributing to increased incidence of ROP included: duration of oxygen therapy, ventilator therapy, total parenteral nutrition and hospitalization, frequency of hyperoxia, hypercarbia, and transfusion and respiratory distress syndrome, umbilical artery catheterization, intraventricular hemorrhage, sepsis, bronchopulmonary dysplasia, use of dexamethasone and aminophylline, pneumonia, air leak syndrome, and hyperglycemia. The incidence of ROP and treated ROP was not influenced by the mode of surfactant treatment(prophylactic vs rescue) in RDS patients and the mode of dexamethasone treatment(short vs long) in BPD patients. CONCLUSION: The risk factors for retinopathy of prematurity included gestational age, birth weight and duration of oxygen, as well as other aforementioned perinatal factors. The occurrence of ROP can be decreased by preventing preterm birth, minimizing the use of oxygen, and further morbidity can be prevented by performing proper ophthalmologic examination and doing an appropriate follow-up.
Aminophylline
;
Birth Weight
;
Blindness
;
Bronchopulmonary Dysplasia
;
Catheterization
;
Catheters
;
Dexamethasone
;
Gestational Age
;
Hemorrhage
;
Hospitalization
;
Humans
;
Hyperglycemia
;
Hyperoxia
;
Incidence
;
Infant
;
Infant, Newborn
;
Infant, Very Low Birth Weight
;
Oxygen
;
Parenteral Nutrition, Total
;
Pneumonia
;
Pregnancy
;
Premature Birth
;
Retinopathy of Prematurity*
;
Risk Factors*
;
Sepsis
;
Umbilical Arteries
;
Ventilators, Mechanical
8.Modification of adriamycin-induced cytotoxicity by recombinant human interferon-gamma and/or verapamil in human stomach cancer cells.
Weon Seon HONG ; Chang Min KIM ; Choon Taek LEE ; Jhin Oh LEE ; Tae Woong KANG
Journal of Korean Medical Science 1992;7(3):236-240
Recombinant human-interferon-gamma (rH-IFN-gamma) and verapamil (VRP), either alone or in combination, were evaluated in MTT assay for their modification effects on adriamycin-induced cytotoxicity against MKN-45, human stomach adenocarcinoma cells. VRP as a single agent did not inhibit the survival of MKN-45 at doses of up to 5.0 micrograms/ml. The survival of MKN-45 was inhibited by rH-IFN-gamma dose-dependently and further inhibited by the addition of VRP. However, the maximum growth inhibition of MKN-45 in any combination treatment with rH-IFN-gamma and VRP was less than 50% except in the highest concentration combinations (% survival: 47.9% at 10(4) U/ml of rH-IFN-gamma and 3.0 micrograms/ml of VRP). Adriamycin caused a concentration-dependent cytotoxicity and its cytotoxicity was significantly enhanced by the addition of rH-IFN-gamma and further enhanced by the combined use of rH-IFN-gamma and VRP. The modification effects of rH-IFN-gamma and VRP on adriamycin-induced cytotoxicity were evaluated in terms of modification index (MI), demonstrating that rH-IFN-gamma significantly increased in adriamycin-induced cytotoxicity and that the combined use of rH-IFN-gamma and VRP enhanced the adriamycin-induced cytotoxicity to a greater extent than did rH-IFN-gamma alone: MI values at 10(2) U/ml and 10(3) U/ml of rH-IFN-gamma were 1.7 and 3.1, respectively; those at 1.5 micrograms/ml and 3.0 micrograms/ml of VRP in the presence of 10(3) U/ml of rH-IFN-gamma were 4.4 and 6.0, respectively.(ABSTRACT TRUNCATED AT 250 WORDS)
Adenocarcinoma/*drug therapy/pathology
;
Antineoplastic Combined Chemotherapy Protocols/pharmacology
;
Cell Survival/drug effects
;
Doxorubicin/*pharmacology
;
Drug Interactions
;
Drug Resistance
;
Drug Screening Assays, Antitumor
;
Humans
;
Interferon-gamma/*pharmacology
;
Recombinant Proteins
;
Stomach Neoplasms/*drug therapy/pathology
;
Tumor Cells, Cultured
;
Verapamil/*pharmacology
9.Osteosarcoma with Adenocarcinoma of Lung in Li-Fraumeni Syndrome: A Case Report.
Chang Seon OH ; Jin Ho LEE ; Sung Taek JUNG ; Bo Ram NA
The Journal of the Korean Bone and Joint Tumor Society 2014;20(2):99-103
Li-Fraumeni syndrome (LFS) is an autosomal dominant hereditary disorder characterised by a variety of different tumor types in children and young adults. That contains with a germline mutation in the tumor suppressor gene Tumor Protein p53 (TP53). That is extremely rare. Furthermore, this is sometimes overlooked. Here, we report a case of LFS which was confirmed by mutational analysis of the p53 gene. Also, literature review is intended to improve understanding of this disease entity.
Adenocarcinoma*
;
Child
;
Genes, p53
;
Genes, Tumor Suppressor
;
Germ-Line Mutation
;
Humans
;
Li-Fraumeni Syndrome*
;
Lung*
;
Osteosarcoma*
;
Young Adult
10.Modification effects of recombinant human tumor necrosis factor and recombinant human interferon-gamma intrinsic and acquired resistance to cisplatin in human stomach and lung cancer cell lines.
Weon Seon HONG ; Chang Min KIM ; Choon Taek LEE ; You Cheoul KIM ; Young Kyuck IM ; Jhin Oh LEE ; Tae Woong KANG
Korean Journal of Immunology 1992;14(1):25-33
No abstract available.
Cell Line*
;
Cisplatin*
;
Humans*
;
Interferon-gamma*
;
Lung Neoplasms*
;
Lung*
;
Stomach*
;
Tumor Necrosis Factor-alpha*